Administrative Core
Administrative Core
批准号:
10394985
负责人:
David S Perlin
金额:
$54.33万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-04-30
关键词:
AddressAdministratorAdvisory CommitteesCommittee MembersDecision MakingDevelopmentEnsureGoalsIndividualIntellectual PropertyLeadLeadershipLegal patentLicensingLogisticsMediationMulti-Drug ResistanceNational Institute of Allergy and Infectious DiseaseNew JerseyOutcomeOutputPerformancePress ReleasesPrincipal InvestigatorProcessProgress ReportsPublicationsReportingResearchResearch InstituteResource AllocationResourcesScheduleSeasonsSite VisitStructureTherapeuticTimeTravelUnited States National Institutes of HealthUniversitiesbaseconflict resolutiondesigndrug developmentexperienceinnovationmaterial transfer agreementmedical schoolsmeetingsmemberorganizational structurepre-clinicalpreclinical developmentproduct developmentprogramspublic health researchrecruitsuccess
中文摘要
摘要
行政核心(行政核心)将建立为一个综合的、确定优先事项的联合体
涉及首席调查员(PI/PD)、CETR内部领导小组和一名科学顾问
委员会(SAC)与NIAID的项目参与,以提高潜在的产品成果。这个
管理职能旨在提供行政支持,促进个人的成功
项目,促进有效整合和分配支助职能和资源,并刺激
CETR成员之间的科学交流,从而确保整个CETR方案实现其
目标。管理核心将由PI中心大卫·佩林博士监督,他将由一名
经验丰富的行政主管和财务总监,负责协调和管理所有行政职能。做到最好
为了推进CETR目标,行政核心将协调项目负责人和他们的
合作者(和分包商)、科学/发现核心主管和SAC成员。这些会议是
旨在通过发现矩阵推进化合物,从而实现及时和客观的“去,不去”
做决定。管理核心还将促进与SAC的年度审查会议,并反向站点
访问NIAID。它将编制并向NIH提交年度进展报告,并将协调研究
出版物、会议介绍、报告和新闻稿。最后,它将是与专利的联系
《经济、社会和文化权利国际公约》产生的知识产权保护和许可小组,以及许可
机遇。管理核心将执行以下具体目标:1)建立高效的
为项目负责人和核心主管提供必要的监督和指导的管理结构;
有效地将科学咨询委员会作为战略顾问整合到发现/发展中
过程,促进科学交流;2)最大限度地配置资源,优先安排化合物
通过以下方式建立关键指标来进行发展:进行、不进行决策和资源分配
支持项目负责人和核心总监的密切互动,并安排定期评审;3)开发
评估年终项目绩效、准备中期和年终报告以及招聘
酌情作为补充项目;4)协调出版物、成果介绍和新闻稿
从这些研究的结果中产生;以及5)建立内部组织结构,以处理
材料转让协议、保密性、知识产权申请和许可机会的后勤
并为解决冲突和其他业务问题制定管理计划。
英文摘要
Abstract
The Administrative Core (Admin Core) will be established as an integrated, priority-setting consortium
involving the Principal Investigator (PI/PD), an internal CETR leadership team, and a Scientific Advisory
Committee (SAC) with programmatic involvement from NIAID to enhance potential product outcome. The
management function is designed to provide administrative support that facilitates the success of individual
Projects, promotes effective integration and allocation of support functions and resources, and stimulates
scientific exchange between CETR members, thus ensuring that the overall CETR program achieves its
objectives. The Admin Core will be overseen by the Center PI, Dr. David Perlin, who will be supported by a
seasoned administrator and financial director to coordinate and manage all administrative functions. To best
advance CETR objectives, the Admin Core will coordinate regular meetings of Project Leaders and their
collaborators (and subcontractors), scientific/discovery Core Directors, and SAC members. The meetings are
designed to advance compounds through the discovery matrix enabling timely and objective “go, no-go”
decision making. The Admin Core will also facilitate an annual review meeting with the SAC, and reverse site
visit at NIAID. It will produce and submit the annual progress report to the NIH, and it will coordinate research
publications, meeting presentations, reports and press releases. Finally, it will be the liaison with the Patent
and Licensing group for the protection of intellectual property generated by the CETR, as well as licensing
opportunities. The Admin Core will execute the following Specific Aims: 1) establish a highly efficient
management structure that provides essential oversight and guidance for Project Leaders and Core Directors,
effectively integrates the Scientific Advisory Committee as strategic advisors in the discovery/development
process, and promotes scientific exchange; 2) maximize allocation of resources and prioritize compound
development by establishing critical metrics for “go, no-go” decision making and resource allocations by
supporting close interactions of Project Leaders and Core Directors and scheduling regular reviews; 3) develop
an effective strategy to assess year-end Project performance, prepare interim and year-end reports, and recruit
a Supplemental project, as appropriate; 4) coordinate publications, presentations of results, and press releases
arising from the output of these studies; and 5) establish an internal organizational structure that addresses
logistics for material transfer agreements, confidentiality, intellectual property filings and licensing opportunities
and negotiations; and develop a managerial plan for conflict resolution and other operational issues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Accelerated development of advanced leads against SARS-CoV-2 and other pandemic viruses
-
批准号:10513922
-
项目类别:
-
资助金额:$388.58万
-
财政年份:2022
-
负责人:David S Perlin
-
依托单位:
Metropolitan AntiViral Drug Accelerator
-
批准号:10513913
-
项目类别:
-
资助金额:$6514.17万
-
财政年份:2022
-
负责人:David S Perlin
-
依托单位:
Administrative Core
-
批准号:10513914
-
项目类别:
-
资助金额:$755.88万
-
财政年份:2022
-
负责人:David S Perlin
-
依托单位:
Animal Model Core
-
批准号:10513920
-
项目类别:
-
资助金额:$558.04万
-
财政年份:2022
-
负责人:David S Perlin
-
依托单位:
A CETR-based partnership accelerator for rapid drug development targeting SARS-CoV-2 and pan-CoVs
-
批准号:10187269
-
项目类别:
-
资助金额:$61.99万
-
财政年份:2020
-
负责人:David S Perlin
-
依托单位:
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
-
批准号:10394984
-
项目类别:
-
资助金额:$663.83万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Critical Factors Influencing Echinocandin Resistance in Candidaglabrata
-
批准号:10451830
-
项目类别:
-
资助金额:$71.06万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negativebacterial infections
-
批准号:10380759
-
项目类别:
-
资助金额:$107.68万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
-
批准号:9898899
-
项目类别:
-
资助金额:$107.06万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Critical Factors Influencing Echinocandin Resistance in Candidaglabrata
-
批准号:10215271
-
项目类别:
-
资助金额:$71.06万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
-
批准号:10337197
-
项目类别:
-
资助金额:$114.2万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Core E Animal Infection Models
-
批准号:10394989
-
项目类别:
-
资助金额:$118.1万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
-
批准号:9923564
-
项目类别:
-
资助金额:$663.81万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Core E Animal Infection Models
-
批准号:10613892
-
项目类别:
-
资助金额:$144.96万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Administrative Core
-
批准号:10613884
-
项目类别:
-
资助金额:$73.49万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
-
批准号:10551227
-
项目类别:
-
资助金额:$114.2万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
-
批准号:10613883
-
项目类别:
-
资助金额:$652.13万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
-
批准号:9926819
-
项目类别:
-
资助金额:$105.13万
-
财政年份:2019
-
负责人:David S Perlin
-
依托单位:
Critical Factors Influencing Echinocandin Resistance in Candida glabrata
-
批准号:8614663
-
项目类别:
-
资助金额:$48.77万
-
财政年份:2014
-
负责人:David S Perlin
-
依托单位:
Critical Factors Influencing Echinocandin Resistance in Candida glabrata
-
批准号:8897999
-
项目类别:
-
资助金额:$52.5万
-
财政年份:2014
-
负责人:David S Perlin
-
依托单位:
海外基金